Jonny Williamson speaks with Dr Eric Mayes, CEO of Cambridge-based Endomag – the pioneering firm behind a new diagnostic tool that could end the postcode lottery for cancer staging.
Every year, almost 55,000 people in the UK are diagnosed with breast cancer. Globally, that number leaps dramatically to 1.7 million, with more than 520,000 deaths. The current accepted method for determining whether breast cancer has spread lies in locating and identifying affected lymph nodes – small bean-shaped organs that form an important part of…
This content is for subscribers only. Subscribe now for free to read the full article.
Already a subscriber? Login
